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Abstract.  An intermediate of 35 kD accumulates tran- 
siently during ER degradation of the H2 subunit of the 
asialoglycoprotein receptor;  it is derived by an en- 
doproteolytic cleavage in the exoplasmic domain near 
the transmembrane  region.  In the presence of cyclo- 
heximide all of the precursor H2 is converted to this 
intermediate,  which is degraded only after cyclohexi- 
mide is removed (Wikstr6m,  L.,  and H. F.  Lodish. 
1991. J.  Cell Biol.  113:997-1007).  Here we have 
generated mutants of H2 that do not form the 35-kD 
fragment,  either in transfected cells or during  in vitro 
translation  reactions in the presence of pancreatic 
microsomes.  In transfected cells the kinetics of ER 
degradation of these mutant proteins are indistinguish- 
able from that of wild-type H2, indicating the exis- 
tence of a  second pathway of ER degradation which 
does not involve formation of the 35-kD fragment. 
Degradation of H2 in the ER by this alternative path- 
way is inhibited by TLCK or TPCK, but neither for- 
mation nor degradation of the 35-kD fragment is 
blocked by these reagents.  As determined by NH2- 
terminal  sequencing of the 35-kD fragment,  formed 
either in transfected cells or during in vitro translation 
reactions in the presence of pancreatic microsomes, 
the putative cleavage sites are between small polar,  un- 
charged amino acid residues.  Substitution of the 
residues NH2- or COOH-terminal to the cleavage site 
by large hydrophobic or charged ones decreased the 
amount of 35-kD fragment formed and in some cases 
changed the putative cleavage site.  Cleavage can also 
be affected by amino acid substitutions (e.g., to pro- 
line or glycine) which change protein conformation. 
Therefore, the endoprotease that generates the 35-kD 
fragment has specificity similar to that of signal pep- 
tidase. 
H2a and H2b are isoforms that differ only by a pen- 
tapeptide insertion in the exoplasmic juxtamembrane 
region of H2a.  100% of H2a is degraded in the ER, 
but up to 30%  of H2b folds properly and matures to 
the cell surface.  The sites of cleavage to form the 
35-kD fragment are slightly different in H2a and H2b. 
Two mutant H2b proteins,  with either a glycine or 
proline substitution at the position of insertion of the 
pentapeptide in H2a, have metabolic fates similar to 
that of H2a.  These mutations are likely to change the 
protein conformation in this region.  Thus the confor- 
mation of the juxtamembrane domain of the H2 pro- 
tein is important  in determining  its metabolic fate 
within the ER. 
C 
ELLULAR homeostasis involves continuous turnover 
of proteins in all cellular compartments.  The endo- 
plasmic reticulum (ER), the site of synthesis of secre- 
tory, membrane, lysosomal, and vacuolar proteins,  is a site 
for protein degradation.  Proper folding and oligomerization 
of  proteins in the ER are prerequisites for further routing into 
the  Golgi  complex  (Lodish,  1988; Hurtley and  Helenius, 
1989; Pelham, 1989). Most misfolded polypeptides and un- 
assembled subunits  of oligomeric proteins  are  eventually 
degraded without exiting the ER. The rapid degradation  of 
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unassembled subunits of several oligomeric membrane pro- 
teins within the ER (reviewed by Klausner and Sitia,  1990; 
Bonifacino  and Lippincott,  1991) is of interest  as it repre- 
sents a pathway for protein degradation  distinct from the well 
studied lysosomal protein breakdown, and it is part of an im- 
portant, but still largely uncharacterized,  regulatory step in 
the cellular secretory pathway. 
There are many examples of selective ER degradation.  Ex- 
pression of the T cell receptor, a, B, or 5 subunits alone, in 
fibroblasts,  or in mutant T cells lead to their rapid degrada- 
tion within the ER, whereas under similar circumstances the 
and ~" chains are metabolically stable (Chen et al.,  1988; 
Lippincott et al., 1988; Bonifacino et al., 1989; Wileman et 
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zyme A (HMG-CoA)  ~  reductase, a transmembrane protein, 
also exhibits regulated degradation in the ER (Chun et al., 
1990;  Inoue  and  Simoni,  1992). Another system which 
exhibits rapid ER degradation is that of the human asialo- 
glycoprotein receptor  H2 subunit, the focus of this study. 
The human asialoglycoprotein (ASGP) receptor is a type 
2 transmembrane  glycoprotein that is normally  expressed 
only on the sinusoidal (basolateral) surface of hepatocytes. 
This Ca2+-dependent lectin binds and removes by receptor- 
mediated endocytosis glycoproteins with carbohydrate side 
chains bearing terminal galactose residues (asialoglycopro- 
teins) (Lodish,  1991; Spiess, 1990). The functional ASGP 
receptor  is  a  hetero-oligomer  consisting  of two  types  of 
subunits,  H1  and H2,  with  a  minimum stoichiometry  of 
(H1)3(H2)~ (Henis et al.,  1990). HI and H2 are 60%  ho- 
mologous  in  amino  acid  sequence  (Spiess et  al.,  1985; 
Spiess  and  Lodish,  1985; Bischoff  and  Lodish,  1987; 
Bischoff et al., 1988). The polypeptide chain of each subunit 
consists  of four  main  domains:  a  short  cytosolic  NH2- 
terminal segment, a single transmembrane segment that also 
functions as an uncleaved signal anchor sequence, a stalk do- 
main, and, at the very COOH  terminus,  the Ca~+-depen  - 
dent galactose binding domain.  There are two subtypes of 
H2: H2a and H2b which differ only by the presence of five 
extra amino acids in H2a near the transmembrane region on 
the exoplasmic side which results from alternative splicing 
of the mRNA.  In Hep G2 hepatoma  cells,  of the H2 ex- 
pressed 90% is H2b and 10% H2a (Lederkremer and l.xxt- 
ish,  1991). 
Shia and Lodish (1989) showed that more than 50%  of 
newly  synthesized H1  subunits,  expressed  without  H2  in 
NIH 3T3 fibroblasts, mature through the Golgi complex to 
the cell surface. In contrast,  all newly made H2a,  synthe- 
sized in fibroblasts without HI, is rapidly degraded in a non- 
lysosomal, pre-Golgi compartment (Amara et al., 1989; Shia 
and Lodish, 1989). H2a is synthesized, inserted into the ER, 
and  core-glycosylated  normally.  However, H2a  remains 
within  the  ER  and  its  carbohydrate  chains  do  not  get 
processed by medial Golgi enzymes. Instead, it is degraded 
in the ER after a lag of ~ 30 min by a process not affected 
by agents that inhibit lysosomal degradation (Wikstr/Sm and 
Lodish, 1991). When H2b is expressed in fibroblasts, ,x,30% 
of newly synthesized protein becomes folded normally, exits 
the ER, and reaches the cell surface while 70 % remains un- 
folded and is degraded in the ER (Lederkremer and Lodish, 
1991; Wikstr~im  and Lodish, 1993). During ER degradation 
of both the H2a and H2b subunlts, a 35-kD fragment ac- 
cumulates transiently; it is formed by proteolytic cleavage in 
the  exoplasmic  domain  near  the  transmembrane  region 
(Wikstr6m and Lodish, 1991, 1992). In the presence of cy- 
cloheximide all of  the precursor H2 is converted to this inter- 
mediate, which is degraded completely only after cyclohexi- 
mide is removed. Thus, we suggested  that proteolytic cleavage 
to generate this 35-kD fragment is an obligatory step in ER 
degradation of H2 (Wikstr6m and Lodish, 1991). 
Here we analyze further two aspects of ER degradation of 
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the H2 subunit. First,  we find that the amino termini of the 
35-kD fragment generated from H2a and H2b are slightly 
different, suggesting a different site of cleavage in each pro- 
tein. The same proteolytic cleavages are observed in an in 
vitro translation system in the presence of pancreatic micro- 
somes. We examined by mutational  analyses of the amino 
acid  residues  NH2- and  COOH-terminal  to  the  cleavage 
sites the sequence specificity of  the cleavage. We find that the 
protease responsible for the formation of  the 35-kD fragment 
prefers to cleave between small neutral or polar  residues. 
Furthermore,  the selection of cleavage site and the extent of 
cleavage is affected by mutations that are thought to alter the 
local conformation of the protein.  Thus,  the specificity of 
this protease is similar to signal peptidase. 
Second, we show that the overall rates and extents of ER 
degradation of H2 mutants that do not generate the 35-kD 
fragment are similar to those of the wild-type protein and to 
H2 mutants which do generate the 35-kD fragment.  Thus, 
the cleavage of the H2 protein to form the 35-kD intermedi- 
ate is not obligatory for ER degradation, despite other evi- 
dence that all H2 can be converted into the 35-kD fragment 
which  is  then  degraded  (Wikstr0m  and  Lodish,  1991). 
Therefore, there are at least two pathways for the ER degra- 
dation of the H2 protein,  one not dependent on the proteo- 
lytic cleavage that generates the 35-kD intermediate.  This 
second ER degradation process can be inhibited by N-tosyl- 
L-lysine  chloromethyl ketone (TLCK), N-tosyl-L-phenylala- 
nine chloromethyl ketone (TPCK),  or iodoacetamide,  but 
these  compounds  do not block  the  cleavage process  that 
forms the 35-kD fragment nor its ultimate degradation. The 
TLCK/TPCK-sensitive ER degradation pathway is probably 
the principal  one that recognizes  and degrades  unfolded 
forms of H2b in the ER, while properly folded forms of the 
protein  mature to the cell surface (Wikstr0m and Lodish, 
1993). 
Materials and Methods 
Materials 
Materials were purchased from sources  previously  listed (Amara et al., 
1989;  Wikstr0m  and Lodish,  1991, 1992).  In addition, reagents and en- 
zymes  for  in  vitro  transcription  and  translation  were  obtained  from 
Promega Corp.  (Madison, Wl). Reagents and enzymes for PCR reactions 
were  from Perkin-Elmer Cetus  Instrs.  (Norwalk,  CT).  Dog pancreatic 
microsomes,  prepared by a standard protocol (Walter and Blobel, 1983), 
were a kind gift from Dr. C. Hwang (Genzyme Corp., Framingham, MA). 
Restriction enzymes were  from  New  England Biolabs (Beverly,  MA). 
Immobilon-P paper was from Millipore Corp.  (Bedford,  MA). The Se- 
quenase 2.0 kit for DNA sequencing  was from United States Biochemical 
Corp.  (Cleveland,  OH). 
In Vitro Transcription and In Vitro Translation 
In vitro transcription/translation reactions were  done as previously  de- 
scribed (Bischoff and Lodish,  1987).  Briefly, mRNAs were  transcribed 
from cDNAs subcloned in pSP64 vectors,  using SP6  RNA polymerase 
following the manufacturer's protocol, mRNAs were translated in nuclease- 
treated rabbit reticulocyte  lysates using [35S]Cys or [3H]Leu as radiolabel, 
in a total reaction volume of 12.5/~l. At the end of the reaction, microsomes 
were isolated by centrifugation at 165,000 g for 15 min through a cushion 
of 0.5 M sucrose,  10 mM Tris, pH 7.4, and 150 mM NaC1. The pelleted 
microsomes were solubilized using lysis buffer (1% Triton X-100, 0.5% so- 
dium deoxycholate, and 10 mM EDTA in phosphate buffered saline, pH 7.4, 
with 2 mM PMSF) or SDS-gel sample buffer (125 mM Tris, pH 6.8, 2% 
SDS,  20%  glycerol,  5%  2-mercaptoethanol, and 0.002%  bromophenol 
blue) for further analysis. 
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Substitution mutations of H2 were introduced by overlap extension PCR 
(Landt et al.,  1990).  The concentrations of reagents and enzymes used in 
the PCR reactions were according to the manufacturer's recommendations. 
Four primers were used to generate each mutation. As an example, the H2a 
$79W mutant was generated with the following four primers: 
primer 1: 5'-CCTCAGAGCAACCTCAG-3', 
corresponding to bp -63 to  -47 of the H2 cDNA sequence (Spiess and 
Lodish,  1985)  (with the starting ATG codon designated as bp 1-3); 
primer 2: 3'-CACCAGTAGACACACTGA-5', 
corresponding to bp 213-230  (antisense); 
primer 3: 5'-GTGGTCATCTGTGTGACTGGGTC~CAAAGTGAG-3', 
corresponding to bp 225-257  (mutant bases are underlined); 
primer 4: 3'-ATGTTGTGTC~TTGGGG-5', 
corresponding to bp 673-689 (antisense). 
The Y-most 18 bp of primer 3 is complementary to the 5'-most 18 bp of 
primer 2. PCR reactions using primers 1 and 2 and templated by the wild- 
type cDNA produced the expected 350-bp fragment. PCR using primer 3 
(which contains the mutated sequence) and primer 4, templated by the wild- 
type cDNA, produced the expected 460-bp product, containing the mutated 
sequence. The two reaction products were then purified by agarose gel elec- 
trophoresis, mixed, and used as templates for the third PCR reaction con- 
taining primers  1 and 4.  The expected 800-bp fragment, containing the 
desired mutant sequence, was digested with Xmal and DraIII, which have 
unique sites within the H2  sequence (bp  -12  and 632,  respectively, to 
generate a 640-bp fragment. This was then gel purified and subeloned into 
a  pSP64 vector containing the wild-type cDNA sequence that had been 
digested with the same enzymes, thereby replacing the wild type with the 
desired mutant sequence. All PCRs were done under the following condi- 
tions:  1 min at 94°C,  1 min at 50°C, and 2  min at 720C  for 30 cycles. 
Primers 1, 2, and 4 were used to generate all of the H2 mutants; primer 
3 was changed at the appropriate positions to generate desired mutations 
at  different positions.  All  mutations  were  verified  by  double-stranded 
dideoxy sequencing using the Sequenase 2.0 kit from United States Bio- 
chemical Corp. 
Cell Culture 
NIH 3T3 cells expressing wild-type H2a (2-18 cells) and H2b (2C cells) 
were kind gifts of Drs. L. WikstI6m (Ludwig Institute for Cancer Research, 
Ludwig, Sweden) and G. Lederkremer (Tel Aviv University, Tel Aviv, Is- 
rael) (Shia and I.xxtish,  1989;  Lederkremer and Lodish, 1991).  NIH 31"3 
cells expressing H2 mutants were generated by using a calcium phosphate 
transfection protocol (Cben and Okayama,  1988),  using the pMEX-neo 
mammalian expression vector (Martin-Zanca et al., 1989) containing mu- 
tant H2 cDNAs subcloned into the BamH1 and EcoRl sites in the multiclon- 
ing site of the vector. Colonies resistant to G418 were subcloned and tested 
for expression of H2 protein by metabolic labeling. All 3T3 cells were cul- 
tured in DME supplemented with 10%  heat inactivated calf serum. 
Metabolic Labeling, Immunoprecipitation, 
and Enzyme Digestions 
Confluent or near confluent (80%) cells in 100- or 60-mm diameter tissue 
culture dishes were labeled with [35S]cysteine or [3H]leucine  using tech- 
niques previously described (Amara et al.,  1989;  Wikstr/im and Lodish, 
1991). 
Antisera against the carboxyl and amino termini of the ASGP receptor 
H2 subunit (Bischoff et al., 1988) were kind gifts of Drs. L. Wikstz6m and 
G.  Lederkremer. Immunoprecipitation and Endo H digestions of cell or 
microsome lysates were done as previously described (Amara et al., 1989; 
Wikstr6m and Lodish,  1991). 
Gel Electrophoresis, Fluorography and 
Scanning Densitometry 
Immunoprecipitates or in vitro translation products were subjected to SDS- 
PAGE using 0.75 mm thick 10 % Laemmli gels and analyzed by fluorography 
using 20 % 2,5-diphenyloxazole as previously described (Bischoff  and Lod- 
ish, 1987).  Autoradiograms were quantitated with a Molecular Dynamics 
(Sunnyvale, CA) laser microdensitometer as previously described (Lodish 
and Kong,  1991). 
Radiosequencing Analysis of the NH2 Termini of the 
35-kD Fragment 
Limited NH2-terminal protein sequencing was performed essentially as 
previously described (Matsudaira, 1990).  Tritium-labeled immunoprecipi- 
tates or in vitro translation products were subjected to SDS-PAGE on 0.75 
mm thick 10%  Laemmli gels and then electroblotted onto prewet Immo- 
bilon-P paper at 0.5 A for 30 min in 10 mM CAPS, pH 11.0, 10% methanol. 
The paper was then rinsed in water and air-dried. Protein bands of interest 
were located on the paper by autoradiography and then excised for auto- 
mated Edman degradation with an Applied Biosystem Inc. (Foster City, CA) 
model 470A protein sequencer. The PTH (phenylthiohydantoin)-amino  acid 
derivatives from each reaction cycle were then subjected to liquid scintilla- 
tion counting. 
Results 
H2a and H2b Are Cleaved at Different Sites Near the 
Transmembrane Region to Form the 35-kD Fragment 
Metabolic labeling of the H2 subunit of the ASGP receptor 
expressed in NIH 3T3 cells demonstrated that the core-glyco- 
sylated ER forms of these proteins undergo rapid degrada- 
tion in the ER (Wikstrtm and Lodish, 1991, 1992). A 35-kD 
proteolytic fragment, observed in the course of degradation 
of the  ER precursor forms,  is  formed in the ER,  and is 
thought to be the first step in the ER degradation of the pro- 
tein (Amara et al.,  1989;  Lederkremer and Lodish, 1991; 
Wikstrtm and Lodish, 1991). The 35-kD fragment can be 
immunoprecipitated by an antiserum specific for the H2 car- 
boxyl terminus but not an antiserum specific for the amino 
terminus, and its molecular weight suggests that it is gener- 
ated by a proteolytic cleavage on the exoplasmic side of the 
protein near the transmembrane region (Amara et al., 1989). 
We used a radiosequencing strategy to determine the NH2- 
terminal amino acid sequence of the 35-kD fragment. 3T3 
fibroblasts were pulse labeled with [3H]leucine and chased 
for 3 h in medium containing 0.5 mM cycloheximide. Under 
these conditions all newly made H2 is converted into the 35- 
kD fragment (Wikstrtm and Lodish, 1991). Because the pro- 
tein contains several leucine residues in the region where 
cleavage occurs, [3H]leucine was used as the radioactive la- 
bel.  The  fragments  were  subjected  to  NH2-terrninal  se- 
quencing by automated Edman degradation. 
Fig.  1 a  shows that the 35-kD cleavage fragment formed 
by H2b in fibroblasts generates three radioactive peaks (ar- 
rows) at cycles 3, 7, and 10 of the Edman degradation. These 
three peaks correlate precisely (and only) to leucines 84, 88, 
and 91  of the  H2b  amino acid sequence.  Therefore,  the 
amino terminus of the H2b 35-kD fragment is Ala82. Fig. 
1 b  shows the results of a  similar radiosequencing of the 
cleavage fragment formed by H2a. Radioactive peaks are de- 
tected at cycles 11, 12, 15, 16, 18, and 19. This pattern indi- 
cates that there must be at least two species of 35-kD frag- 
ment which differ by only one amino acid residue at the 
amino terminus. One would generate pH]leucine peaks at 
cycles 11, 15, and 18, corresponding positions 89, 93, and 96 
of the H2a amino acid sequence, and thus its amino terminus 
would  be  Ser79.  The  other  would  generate  [3H]leucine 
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Figure 1. Determination of the cleavage site of H2b and H2a that 
generates  the 35-kD fragment in NIH 3T3 fibroblasts.  10 million 
3T3 cells expressing  either H2b (a) or H2a (b) were pulse labeled 
with 0.3 mCi/ml of [3H]Leu for 30 min and chased in unlabeled 
medium containing 0.5  mM cycloheximide  for 3  h.  Cells  were 
lysed in lysis buffer,  immunoprecipitated with the anti-carboxyl- 
terminal H2 antiserum, and subjected to SDS-PAGE. Proteins were 
electroblotted  onto Immobilon-P paper  and the  35-kD cleavage 
fragment located by autoradiography.  Bands on the paper were then 
cut out for NH2-terminal protein sequencing  and the radioactivity 
of each cycle of the Edman degradation was determined by liquid 
scintillation  counting.  Arrows indicate positions  where radioactive 
leucines  were detected.  From the known amino acid sequence  of 
this  region, the position of these radioactive  peaks  were extrapo- 
lated to determine the cleavage site. (c) Results of radiosequencing 
of intracellular  35-kD fragment: A indicates  a deduced cleavage 
site. The underlined  section is the putative transmembrane region. 
The residues  in H2a represented  in shadow are not found in H2b. 
Figure 2. Formation of the 35-kD fragment during in vitro transla- 
tion of H2 mRNA and in transfected cells. Lanes 1 and 2:3T3 cells 
expressing H2a were pulse labeled with 35S-Cys for 30 min, chased 
for 2 h with 1 mM 2,4-dinitrophenol, 5 mM 2-deoxyglucose,  and 
0.5 mM cycloheximide,  and then lysed in lysis buffer. Lanes 3 and 
4: H2a mRNA was translated with l~sS]Cys in a rabbit reticulocyte 
lysate with dog pancreatic microsomes for 2 h. At the end of reac- 
tion,  the microsomes were pelleted  and then solubilized  in lysis 
buffer. All samples were immunoprecipitated with antisera specific 
for the H2 carboxy terminus,  treated with (lanes 2 and 4) or without 
Endo H (lanes I  and 3), and analyzed by SDS-PAGE and fluorog- 
raphy. Solid arrows indicate  the intact protein. Open arrows indi- 
cate the cleavage fragment. 
peaks at cycles 12,  16,  and  19,  corresponding leucines  89, 
93,  and 96; its deduced amino terminus  would be Gly78. 
If  we assume that the 35-kD fragments are formed by a sin- 
gle endoproteolytic cleavage with no further trimming of the 
amino terminus,  the amino termini of the 35-kD fragments 
would correspond to the cleavage sites (Fig.  1 c).  H2b ex- 
hibits a  single cleavage site between Ser81  and Ala82,  and 
H2a  exhibits  two  cleavage  sites,  one  between  Thr77  and 
Gly78, and the other between Gly78 and Ser79.  Therefore, 
H2a and H2b utilize different cleavage sites for formation of 
the 35-kD fragment. For both proteins the cleavage sites are 
between  small  uncharged  or  small  polar  residues  and the 
cleavage site in the H2b is at the position where the five extra 
amino acids are inserted  in H2a. 
The 35-kD Fragment Is Produced by 
In Vitro Translation of H2a or H2b mRNA in the 
Presence of Microsomes 
Lane 3 of Fig. 2  shows that when H2a mRNA (synthesized 
by in vitro transcription of the corresponding cDNA) is sub- 
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Figure 3. Radiosequencing of 35-kD fragment of H2b (a) and H2a (b) produced by in vitro translation. H2b (a) or H2a (b) mRNA was 
translated for 2 h with [3H]Leu in a rabbit reticulocyte lysate with dog pancreatic microsomes. At the end of the reaction, the microsomes 
were pelleted, solubilized in lysis buffer and then subjected to SDS-PAGE. Proteins were electroblotted onto Immobilon-P paper and the 
35-kD cleavage fragment located by autoradiography. Bands on the paper were then cut out for NH2-terminal protein sequencing and 
radioactivity of each cycle of the Edman degradation was determined by liquid scintillation counting. Arrows indicate positions where 
radioactive leucines were detected. From the known amino acid sequence of  this region, the position of  these radioactive peaks were extrapo- 
lated to determine the cleavage site. 
jected to in vitro translation in a rabbit reticulocyte lysate in 
the presence of dog pancreatic microsomes, a 35-kD frag- 
ment (open arrow) is observed in addition to the expected 
full-length 43-kD core-glycosylated  H2a (solid arrow). Lane 
4 shows that both of these species are sensitive to Endo H 
(endoglycosidase H) digestion. Lane 1 shows that the full- 
length H2a and the 35-kD H2a fragment formed in trans- 
fected fibroblasts exhibit the same gel mobility as the corre- 
sponding species synthesized in vitro (lane 3). Lane 2 shows 
that the full-length and 35-kD  fragments formed in fibro- 
blasts are sensitive to Endo H digestion and that they also 
have the same gel mobility as the in vitro products (lane 4). 
The 35-kD  fragment is formed only if microsomes are 
present during the in vitro translation. It is immunoprecipi- 
tated only by antisera specific for the carboxyl terminus but 
not the amino terminus of H2, and it is present inside the 
microsomes as it is totally protected from digestion by pro- 
teinase K unless detergents are added to permeabilize the 
microsomes (data  not shown).  Identical results  (data  not 
shown) were observed by in vitro translation of H2b mRNA 
in the presence of microsomes. To confirm that these 35-kD 
fragments formed in vitro are identical to those formed in 
fibroblasts, they were subjected to radiosequencing analyses. 
Fig. 3, a and b show that the 35-kD fragments formed in vitro 
from both H2b and H2a mRNA have the NH2-terminal se- 
quences,  and thus  the  same  cleavage sites  (H2b between 
Ser81 and Ala82,  H2a between Thr77 and Gly78, and be- 
tween Gly78 and Ser79), respectively, as those generated in 
intact cells (compare to Fig. 1). This result also confirms that 
the 35-kD fragment is formed in the ER without the need for 
vesicular transport (Wikstrfm and Lodish, 1992). The full- 
length H2a and H2b proteins and fragments produced during 
the in vitro translation reaction are stable and do not undergo 
further degradation, even after incubations of over 24 h after 
the termination of  protein synthesis (data not shown). In con- 
trast,  both the core-glycosylated precursor and the 35-kD 
fragment formed in fibroblasts are quickly degraded (Amara 
et al.,  1989). 
Substitution of Residues Around the Cleavage 
Sites with Large Hydrophobic  or Charged Amino 
Acids Inhibit Formation of the 35-kD Fragment 
During In Vitro Translation 
Analysis of the sequence specificity of the cleavage process 
can provide important information regarding the proteolytic 
enzyme involved. Therefore, we constructed a  number of 
substitution mutants around the putative cleavage sites of I-I2a 
and H2b, and analyzed the amount and NH2 termini of the 
35-kD fragment formed by these mutant proteins.  As the 
residues surrounding the cleavage sites are small, polar, and 
noncharged, we suspected that signal peptidase may be re- 
sponsible for this proteolytic cleavage (von Heijne, 1986). If 
this were true, substituting these residues with large hydro- 
phobic or charged ones should cause a decrease in amount 
of cleavage (Folz et al.,  1988;  Shaw et al.,  1988). The in 
vitro translation system was used initially to screen mutants 
for changes in the formation of the 35-kD fragment. 
Since H2b exhibits only a single putative cleavage site, we 
first constructed two sets of H2b mutants,  changing either 
the residue NH2-terminal to the cleavage site (Ser81) or the 
COOH-terminal residue (Ala82).  mRNAs  encoding these 
mutant proteins were synthesized by in vitro transcription 
and then translated in vitro, and the amount of intact I-I2 pro- 
tein and 35-kD fragment formed quantified by scanning den- 
sitometry. All mutant proteins studied were inserted nor- 
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Species  Sequence 
Amount of 35-kD 
fragment formed  Formation of 
in vitro  35-kD fragment 
(wild type  =  1)  in fibroblasts 
81  82 
l-I2b wild type  V 1CVTGSQS ^AQLQAELR 
a.  H2b Ser 81  Mutants:  81  s2 
Ser81Ile  V I CVTGSQI  AQLQAELR 
81  82 
Ser8lTrp  V l CVTGSQW  AQLQAELR 
81  82 
Ser81Arg  V I CVTGSQR  AQLQAELR 
81  82 
Ser81Lys  V I CVTGSQK  AQLQAELR 
81  82 
SerS1Asn  V I CVTGSQN  AQLQAELR 
81  82 
SerS1Pro  V I CVTGSQP  AQLQAELR 
81  82 
SerS1Gly  V I CVTGSQG  AQLQAELR 
81  82 
Ser81Ala  V I CVTGSQA  AQLQAELR 
b.  H2b Ala  82  Mutants:  81  82 
Ala82Pro  V I CVTGSQS  PQLQAELR 
81  82 
Ala82Gly  V I CVTGSQS  GQLQAE/R 
81  82 
Ala82Arg  V I CVTGSQS  RQLQAELR 
81  82 
Ala82Thr  V I CVTGSQS  TQLQAELR 
81  82 
Ala82Glu  V I CVTGSQS  EQLQAELR 
81  82 
Ala82His  V I CVTGSQS  HQLQAELR 
1  + 
0.50 
0.54 
0.47 
0.55 
0.80  + 
1.06  + 
2.60  + 
2.68  + 
1.37  + 
0.97  + 
0.91  + 
1.26  + 
1.44  + 
I. 14  ND 
77  78  79  82 
c.  H2a wild type  V I CVT  G  SQSEGHRGAQLQAELR  1  + 
H2a Mutants:  77^78 ~9 
Ser79Pro  V ICVT  G  PQSEGHRGAQLQAELR  0.29  - 
77  78  79 
Ser79Trp  V I CVT  G  WQSEGHRGAQLQAELR  0.35  - 
77  78  79 
Gly78Trp  VICVT  W  SQSEGHRGAQLQAELR  0.23  - 
77  78  79 
Gly78Arg  VICVT  R  SQSEGHRGAQLQAELR  0.27  - 
77  78  79 
Thr77Trp  V ICVW  G  SQSEGHRGAQLQAELR  0.22  - 
77  78  79 
Gly78Pro  VlCVT  P  SQSEGHRGAQLQAELR  0.82  + 
77  78  79 
Glu82Ala  V I CVT  G  SQSAGt-IRGAQLQAELR  0.77  + 
Boldface indicates the mutant residue. "indicates deduced cleavage site(s) in the wild type proteins.  The underlined section is part of the putative transmembrane 
region.  Residues  in italics are  the  five extra  amino acids in H2a.  In vitro translations:  mRNA encoding  H2  wild-type or mutant protein  was translated with 
[3sS]Cys in rabbit reticulocyte lysates in the presence of dog pancreatic microsomes for 2 h. Pelleted microsomes were immunoprecipitated, treated with Endo H, 
and then subjected to SDS-PAGE.  Intact H2 protein and the 35-kD cleavage fragment were detected by fluorography, quantitated by scanning densitometry,  and 
normalized to the number of cysteine residues. The extend of endoproteolytic cleavage of each sample was calculated as the fraction of the fragment relative to 
total (intact plus fragment) H2. (The average extent of cleavage of the wild type H2a was 0.3 and that of the H2b was 0.2).  The extent of cleavage of each mutant 
was normalized to the value of the wild-type protein from the same experiment, set at 1.0. Intact fibroblasts: 3T3 cells expressing H2 wild-type or mutant proteins 
were pulse labeled with [35S]Cys for 15 min, chased with 0.5  mM cyclobeximide in unlabeled medium for 3 h, and then lysed in lysis buffer. The cell lysates 
were immanopreeipitated  with anti-carboxyl-terminal  H2 antisera and analyzed by SDS-PAGE and fluorography.  +  indicates that 35-kD fragment is detected. 
-  indicates that the fragment  is not detected.  ND,  not determined. 
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H2b Wild type:  VICVTG  SQS  AQLQAELR 
^ 
H2b Mutants: 
$811:  VICVTG  SQ I  AQLQAELR 
^ 
$81R:  VICVTG  SQR  AQLQAELR 
^ 
S81G:  VICVTG  SQG  AQLQAELR 
^ 
$81A:  VlCVTG  SQA  AQLQAELR 
^ 
A82R:  VICVTG  SQS  RQLQAELR 
A82P:  VICVTG  SQS  PQLQAELR 
^ 
A82G:  VICVTG  SQS  GQLQAELR 
^ 
A82T:  VICVTG  SQS  TQLQAELR 
^  ^ 
A82E:  VICVTG  SQS  EQLQAELR 
^  ^ 
Figure  4.  Determination  of 
cleavage site of H2b mutants 
by radiosequencing of 35-kD 
fragment produced during in 
vitro translation. H2b mutant 
mRNAs were translated with 
[3H]Leu in rabbit reticulocyte 
lysates  with  dog  pancreatic 
microsomes  for 2  h.  At the 
end of  the reaction, the micro- 
somes were pelleted,  solubi- 
lized in lysis buffer, and then 
subjected to SDS-PAGE. Pro- 
teins were electroblotted onto 
Immobilon-P  paper  and  the 
35-kD cleavage fragment lo- 
cated by autoradiography. The band on Immobilon-P paper was 
then excised for NH2-terminal protein sequencing and radioactiv- 
ity of  each cycle of  the Edman degradation was determined by liquid 
scintillation counting. From plots of radioactivity against reaction 
cycles, peaks corresponding to [3H]Leucines  were determined and 
data extrapolated to determine the cleavage site. Boldface indicates 
the mutant residue. A indicates a deduced cleavage site. The under- 
lined section is part of the putative transmembrane region. 
mally into microsomal membranes and were N-glycosylated 
(data not shown). For each mutant protein, the fraction of 
the amount of 35-kD fragment relative to the total (intact and 
fragment) was calculated and then normalized to that of the 
wild-type protein which is given a reference value of 1.0. Ta- 
ble I a, column 3, summarizes the data from H2b mutants 
in which Ser81 residue was mutated. Mutation of Ser81 to 
a large hydrophobic (Ile, Trp) or positively charged residue 
(Arg, Lys) causes a twofold decrease in the amount of 35-kD 
fragment formed during in vitro translation.  Two mutants 
(S81P and S81N) generate amounts of 35-kD fragment simi- 
lar to that of the wild type while two mutants  (S81A and 
S81G) generated twofold increased amounts of the  35-kD 
fragment. 
These results are consistent with the notion that  signal 
peptidase may be responsible for the cleavage, as this pro- 
tease normally does not cleave COOH-terminal to large hy- 
drophobic or positively charged residues. However, the $8 lI, 
S81W,  S81R,  and S81K mutants do generate some 35-kD 
fragment formation, and this might be due to a change in the 
position of the cleavage site. Therefore, the amino termini of 
the H2b S81R and $81I 35 kD fragments produced in vitro 
were determined by radiosequencing. Fig. 4 shows that the 
NH2 termini of the H2b S81R and S81I 35-kD fragments, 
defining the putative cleavage site, have been shifted from 
that of the H2b wild-type site ($81/A82)  to G78/$79, one of 
the cleavage sites used by H2a. In contrast, radiosequencing 
of the 35-kD fragments formed during in vitro translation of 
the H2b S81G and S81A mutants,  which exhibit increased 
amounts of 35-kD fragments, showed that the putative cleav- 
age sites are the same as wild type (Fig. 4). 
Six mutants of Ala82 in H2b were also analyzed (Table I 
b). No mutant showed any significant change in the amount 
of 35-kD fragment formed during in vitro translation (col- 
unto 3). However, analyses of the NH2 termini of these 35- 
kD fragments showed that the cleavage sites of the A82P and 
A82G mutants are shifted from that of  the H2b wild-type site 
($81/A82)  to G78/$79,  one of the cleavage sites found in 
H2a. The A82E and A82T mutants generated two species of 
35-kD fragments, with NH2 termini corresponding to that 
of  the H2b wild-type $81/A82 and to cleavage at the G78/$79 
site. The A82R mutant exhibited only cleavage at the wild- 
type $81/A82  site. 
A less extensive mutational analysis was done with H2a 
(Table I c). The putative cleavage sites of the wild-type H2a 
that generate the 35-kD fragment are T77/G78 and G78/$79. 
Mutants of T77, G78, or $79 were constructed and analyzed 
for amount of 35-kD fragment formation during in vitro trans- 
lation in the presence of microsomes.  The T77W,  G78W, 
G78R,  and $79W mutants  showed significantly (70-80%) 
decreased formation of  the 35-kD fragment. All of  these mu- 
tants either have a large hydrophobic amino acid (Trp) or a 
positively charged residue  (Arg)  adjacent  to the putative 
cleavage site.  Interestingly, the  $79P mutant,  but not the 
G78P mutant, also exhibited a large decrease in formation 
of the 35-kD fragment. 
Mutations That Cause a Decrease in Formation 
of the 35-kD Fragment during In Vitro Translation 
Also Cause a Decrease in the Amount of 35-kD 
Fragment Formed in Intact Fibroblasts 
The cDNAs encoding the H2a and H2b mutants were sub- 
cloned into a mammalian expression vector and then trans- 
fected into NIH 3T3 cells to form stable cell lines. These 
were used to study the effect of the mutations on the forma- 
tion of  the 35-kD fragment in intact cells. All the mutant pro- 
teins studied were properly inserted into the ER and became 
N-glycosylated. The extent of formation of the 35-kD frag- 
ment was determined by experiments in which cells express- 
ing the H2 mutants were pulse labeled and then chased in 
unlabeled medium containing cycloheximide. In  cells ex- 
pressing the wild-type H2 proteins the presence of  cyclohexi- 
mide in the chase medium results in conversion of all newly 
synthesized H2  into  the  35-kD  fragment  (Wikstr6m  and 
Lodish, 1991). The presence or absence of the 35-kD frag- 
ment in  cells  expressing the mutants  was  determined,  as 
shown for two typical mutants in Fig. 5. Both the H2b S81G 
and the H2b S81W mutants are synthesized as 43-kD core- 
glycosylated precursors (Fig. 5, lanes 1 and 3, respectively, 
solid arrow). During a chase of 3 h in the presence of cyclo- 
heximide the  S81G mutant clearly produces much 35-kD 
fragment (lane 2,  open arrow) but the S81W  mutant pro- 
duces no 35-kD fragment (lane 4). Column 4 of Table I sum- 
marizes the results obtained in similar studies for all our H2a 
and H2b mutants.  When the H2b S81I,  S81W, S81R,  and 
S81K mutants  are  expressed in  fibroblasts,  no detectable 
amount of 35-kD fragment is observed. However the H2b 
S81P, S81G, S81A, and $81N mutants form wild-type levels 
of the  35-kD  fragment.  Similarly, the  H2b A82G,  A82E 
A82R,  A82E,  and  A82T  mutants  produce approximately 
normal amounts of the 35-kD cleavage fragment. No detect- 
able amount of the 35-kD fragment (or any other immuno- 
precipitable fragment) was detected in cells expressing the 
H2a T77W,  G78W, G78R,  $79W,  and $79P mutants,  but 
wild-type amounts of the 35-kD fragment were formed by 
the G78P and E82A mutants. 
Therefore, all H2a and H2b mutants which exhibit a sig- 
nificant decrease in the amount of 35-kD fragment formed 
during in vitro translations generate no detectable amount of 
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Figure 5. Formation of  the 35-  o~ 
kD fragment in fibmblasts  ex-  '7. 
pressing  H2b mutant proteins  "~ 
S81G and S81W. 3T3 cells ex-  E 
pressing  H2b  S81G  or  H2b 
S81W were pulse labeled with 
0.3 mCi/ml of PS]Cys for 15 
rain,  chased  with  0.5  mM  cy- 
cloheximide in unlabeled me-  •  ft. 
dium for 3 h, and then lysed in 
lysis  buffer.  The  cell  lysate 
was immunoprccipitated with  o 
antisera  specific  for  the  H2 
carboxyl  terminus  and  ana-  "~ 
lyzed by SDS-PAGE and fluo- 
rography.  The  solid  arrow 
indicates  the  position  of the 
43-kD core-glycosylated pro-  (b) 
tein and the open arrow indi- 
cates the position of  the 35-kD 
fragment.  The  striped  arrow 
indicates  the  complex  gly- 
cosylated form. P, sample that 
is pulse labeled only; C, sam- 
ple that is  pulse  labeled  and 
then chased with 0.5 mM cy- 
cloheximide in unlabeled me- 
dium for 3 h. 
35-kD fragment in transfected fibroblasts. All mutants which 
generated a normal or above-normal amount of 35-kD Hag- 
ments  during  in  vitro  translations  formed,  in  transfected 
cells,  approximately normal amounts of a 35-kD fragment. 
We did not determine  the NH2 termini  of the 35-kD frag- 
ments generated in cells expressing the mutant proteins, and 
we assume that they are identical to those generated during 
in vitro translations in the presence of microsomes (summa- 
rized in Fig. 4). 
These experiments demonstrate that the protease responsi- 
ble for formation of the 35-kD cleavage fragment prefers to 
cleave between small neutral or small polar residues.  Large 
hydrophobic or charged amino acids  at either  side  of the 
cleavage site are inhibitory. Mutations which may affect the 
conformation of the protein around the putative cleavage site 
(e.g., H2b A82G or A82P mutations) appear to affect the po- 
sition of the cleavage. We therefore suspect that signal pepti- 
dase,  which  has  such  properties  (Nothwehr  and  Gordon, 
1989), or a protease in the ER with similar sequence spec- 
ificity,  is  responsible  for generating  the  35-kD  fragment. 
However, we do not have direct evidence for this hypothesis. 
Mutant H2a and H2b Proteins Which Do Not Generate 
the 35-kD Cleavage Fragment Exhibit Normal Kinetics 
of  ER Degradation in Transfected Fibroblasts 
If ER cleavage of the H2 protein to form the 35-kD fragment 
Figure 6. Kinetics of ER degradation of mutant H2a and H2b pro- 
teins  in transfected  fibroblasts.  3T3 cells  expressing  wild-type or 
mutant I-I2 proteins  were pulse labeled  with 0.3 mCi/ml of [35S]- 
Cys for 15 min and then chased in unlabeled medium for up to 4 h. 
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Anti-H2  immunoprecipitates  of cell  lysates  made  after  various 
times of  chase were subjected to SDS-PAGE. The 43-kD high man- 
nose precursor was detected  by fluorography and quantitated  by 
scanning densitometry.  (a) Pulse chase of H2a wild type and mu- 
tants.  (b) Pulse chase of H2b wild type and mutants at Ser81 that 
do not generate a 35-kD fragment.  (c) Pulse chase of H2a wild 
type, H2b wild type, and H2b mutants at AlaS2. 
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rate of ER degradation of H2 mutant proteins that do not 
generate the 35-kD fragment to be significantly slower than 
that of the H2 wild type. To study the kinetics of the ER 
degradation of various H2 mutant proteins, fibroblasts ex- 
pressing H2 proteins were pulse labeled and then chased in 
unlabeled complete medium for up to 4 h. The amount of 
the 43-kD core-glycosylated  ER precursor was monitored at 
intervals (Fig. 6). 
Fig.  6 a  shows a comparison of the H2a wild type with 
seven different mutants. After a lag of 30-60 min, the core- 
glycosylated precursor of the wild-type H2a protein is de- 
graded rapidly (half-life of ~1  h) with kinetics similar to 
those previously described (Amara et al.,  1989). After 4 h 
of chase,  less than  10% of the pulse labeled precursor re- 
mains. The core-glycosylated precursors of the five mutants 
that do not generate a 35-kD fragment (G78W, G78R, $79P, 
$79W, and T77W) and the two which do (G78P and E82A) 
are degraded at rates similar to that of the H2a wild type. 
For the mutants G78W, G78R, $79P, $79W, and T77W, no 
35-kD (or other) fragment was seen at any time during the 
pulse or chase (data not shown). Among the different mutant 
cell lines there are differences in the extent of the lag period 
prior to degradation. However, these variations are not re- 
producible and may be due to slightly different metabolic 
states of the cells at the time of the experiment. Similar to 
the wild type, none of  the H2a mutants studied generated any 
detectable amount of the 50-kD complex-glycosylated Endo 
H-resistant form (data not shown). Therefore, H2a mutant 
proteins that are not cleaved to form the 35-kD fragment do 
not escape ER degradation and do not reach the medial Golgi 
where complex oligosaccharides are attached. 
Fig. 6 b shows that the rate of ER degradation of the core- 
glycosylated precursors of several mutants H2b proteins that 
do not form a  35-kD fragment ($81I,  S81R,  S81W)  is the 
same as that of the H2b wild type (solid squares). For these 
mutants no 35-kD (or other) fragment was seen at any time 
during  the  pulse or chase  (data  not shown).  The rate of 
degradation of the ER precursors of the S81P, S81A, S81G, 
and S81N mutants that do generate the 35-kD fragment is 
similar to that of the H2b wild type (data not shown). 
About 30%  of newly made H2b wild-type protein folds 
properly in the ER and matures to the cell surface (Leder- 
kremer and Lodish, 1991). The other 70% is degraded in the 
ER. Table II shows that, for all of the $81 mutant proteins 
studied,  ~25-40%  of the  pulse  labeled  protein acquires 
complex oligosaccharides by 4 h of chase. Thus, transport 
of these mutant proteins from the ER to the Golgi and even- 
tually  to  the  cell surface is  normal.  Thus,  H2b  mutants 
which do not generate a 35-kD fragment in the ER do not 
persist  for longer periods in that organelle nor do a  sig- 
nificantly  greater  fraction  acquire  complex  oligosaccha- 
rides. All the mutant $81 proteins exhibit normal rates of ER 
degradation of the ER core-glycosylated precursor, regard- 
less of the ability to form the 35-kD fragment. Therefore, the 
cleavage event that  generates  the  35-kD  fragment is  not 
obligatory for ER degradation of H2b proteins. 
H2b Ala82Pro and Ala82Gly Mutants Have Metabolic 
Fates Similar to That of the Wild-type H2a 
H2a and H2b have very different metabolic fates in fibro- 
Table II. Fraction of Pulse Labeled H2b Protein Acquiring 
Complex Oligosaccharides  After a 4 h  Chase 
Fraction complex 
Species  glycosylated at 4 h 
H2b wt  0.31 
H2b $81I  0.39 
H2b $81R  0.33 
H2b $81W  0.32 
H2b S81N  0.40 
H2b $81P  0.28 
H2b  S81G  0.26 
H2b SS1A  0.33 
H2b A82P  0 
H2b A82G  0 
H2b A82R  0.41 
H2b A82T  0.30 
H2b A82E  0.42 
3T3 cells expressing H2b wild type or mutants were pulse labeled  with 0.3 
mCi/ml of [3~S]Cys for 15 min and then chased in unlabeled medium for 4 h. 
Immunoprecipitates of cell lysates were subjected to SDS-PAGE. The 50-kD 
complex-glycosylated forms of H2 were detected by fluorography and quanti- 
tared by scanning densitometry, relative to the total  amount of H2 precursor 
after a pulse label. 
blasts although H2a differs from H2b only by having five ex- 
tra amino acids inserted between Ser81 and Ala82. All ER 
core-gly~osylated  H2a is degraded in the ER while, as noted, 
•30%  of H2b matures to the cell surface (Lederkremer and 
Lodish,  1991; Wikstr6m and Lodish,  1993). As described 
above, H2a and H2b are cleaved at different sites to generate 
the 35-kD  fragments.  In vitro translation studies  (Fig.  4) 
showed that the putative cleavage sites that generate the 35- 
kD fragment from the precursor of  the mutant H2b A82P and 
A82G proteins are not the one used by the wild-type H2b, 
but are one of the two cleavage sites used by wild-type H2a. 
Fig. 6 c compares the kinetics, in transfected fibroblasts, 
of ER degradation of  the core-glycosylated  precursors of five 
H2b mutants,  A82P,  A82R, A82T, A82G, and A82E, with 
those of  the H2a and H2b wild types. The H2a wild-type pro- 
tein (solid squares) exhibits a faster rate of degradation than 
the H2b wild-type protein (solid triangles). The ER precur- 
sors of three of the H2b mutants, A82R, A82T, and A82E, 
exhibit a rate of degradation similar to the H2b wild type. 
The fractions of  A82R, A82T, and A82E protein that acquires 
complex oligosaccharides are also similar to that of the H2b 
wild type (Table II). In contrast, the ER precursors of the 
H2b A82P (Fig. 6 c, open squares) and A82G (open circles) 
mutants exhibit a  faster rate of degradation than the H2b 
wild-type (solid triangles). The rates of ER degradation of 
these two mutant proteins are similar to that of wild-type 
H2a rather than H2b. Equally significant, none of the pulse 
labeled precursors of these two mutant proteins  acquires 
complex-glycosylated  (Golgi-processed)  oligosaccharides (Ta- 
ble II), another characteristic of H2a. 
Thus, the H2b A82G and A82P mutants have a metabolic 
fate similar to that of H2a; they are degraded very rapidly 
and no detectable fraction matures from the ER to the Golgi. 
However, with respect to the rate of ER degradation and the 
ability of a fraction of the protein to mature to the Golgi, the 
H2b A82E mutant has the same metabolic fate as H2b, not 
H2a (Fig. 6 c; Table II), although this mutant has a glutamate 
residue at position 82,  as does wild-type H2a (Fig.  1 c). 
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degradation in transfected fibroblasts of the core-glycosylated pre- 
cursors of the H2a wild type and H2a G'/SR mutant proteins.  3T3 
ceils expressing the H2a wild type or G78R mutant proteins were 
pulse  labeled with 0.3  mCi/ml of [35S]Cys for 15 min and then 
chased in unlabeled complete medium containing various inhibi- 
tors for 4 h. Immunoprecipitates  of cell lysates were analyzed by 
SDS-PAGE and fluorography. Lanes 1 and 6: Pulse labeled only. 
Lanes 2 and  7: Chased in medium without any inhibitors.  Lanes 
3 and 8: Chased in medium with 100 #M TLCK. Lanes 4 and 9: 
Chased in medium with 20/zM TPCK. Lanes 5 and 10: Chased 
with 30/zM iodoacetamide (IAA). The G78R mutant does not form 
the 35-kD cleavage product. The solid arrow indicates the position 
of the coreglycosylated ER precursor and the open arrow the posi- 
tion of the 35-kD fragment. P, samples that ate only pulse labeled; 
C, samples that are pulse labeled and then chased for 4 h without 
any inhibitor. 
Therefore, the difference in metabolic fates between wild- 
type H2a and H2b is not caused by the presence of glutamate 
(the most NH2-terminal of the five amino acid insert) at po- 
sition 82 in H2a. Furthermore, the H2a E82A mutant has an 
Ala residue at position 82, the same residue found at this po- 
sition in H2b (Fig.  1 c). This mutant has the same metabolic 
fate as wild-type H2a (Fig.  6 a);  no complex-glycosylated 
forms are generated.  Thus, the nature of the amino acid at 
residue 82  is unlikely to be a  determinant of the different 
metabolic fates of the two H2 isoforms. More likely, the pen- 
tapeptide present in H2a introduces a conformational change 
in this region of the protein which blocks folding of the ex- 
oplasmic  domain  and/or  labilizes  the  protein  to  the  ER 
degradation machinery, and this change can be mimicked by 
introduction of proline or glycine residues at residue 82 of 
H2b. 
TLCK, TPCK, and Iodoacetamide Block ER 
Degradation of  Both V~ld-type H2 and Mutants That 
Do Not Form the 35-kD Fragment 
The  ER degradation of H2  can be inhibited by TLCK or 
TPCK (Wikstr6m and Lodish,  1991,  1992).  Fig.  7  shows 
that TLCK, TPCK, or iodoacetamide inhibit ER degrada- 
tion in fibroblasts of both the core-glycosylated precursors 
of H2a wild type (lanes 3-5) and of the H2a G78R mutant 
which does not generate any 35-kD fragment (lanes 6-10). 
Over 90 % of the 43-kD core-glycosylated protein (solid ar- 
row) labeled during the pulse (lanes I  and 6) is degraded af- 
ter 4 h of chase in the absence of any inhibitors (lanes 2 and 
7). The presence of 100 #M TLCK (lanes 3 and 8) or 20 #M 
TPCK  (lanes  4  and  9)  in  the  chase medium inhibits  ER 
Figure 8. TLCK does not inhibit degradation of  the 35-kD fragment 
in transfected cells. 3T3 cells expressing wild-type H2a were pulse 
labeled with 0.3 mCi/ml of [3~S]Cys for 15 min and then chased in 
unlabeled complete medium containing 0.5 mM cycloheximide for 
5 h (lane/). Cycloheximide was then removed and medium without 
any inhibitor (lanes 2, 4, and 6) or medium with 100 #M TLCK 
(lanes 3, 5, and 7) was added and the chase continued for 1 (lanes 
2  and 3), 2  (lanes 4 and 5),  or 3 (lanes 6 and  7) more h.  Im- 
munoprecipitates of cell lysates at various time points after removal 
of cycloheximide were analyzed by SDS-PAGE and fluorography. 
Arrow indicates position of the 35-kD fragment.  Time points on 
figure refer to time after the removal of cycloheximide. 
degradation,  as  shown by the  accumulation of the  43-kD 
core-glycosylated protein. The presence of 30 #M iodoacet- 
amide in the chase medium (lanes 5 and 10) also inhibits ER 
degradation. Like TPCK and TLCK (Wikstr6m and Lodish, 
1991),  this concentration of iodoacetamide does not affect 
maturation  of ASGP  receptor H1  subunit  proteins  to  the 
Golgi (data not shown), indicating that it does not generally 
inhibit cellular functions.  In experiments not shown here, 
TLCK, TPCK, and iodoacetamide blocked ER degradation 
of H2a mutants that do not generate any 35-kD fragment 
(T77W, G78W, $79W,  $79P) as well as H2a mutants that do 
(G78P,  E82A). 
TLCK and TPCK Do Not Inhibit Formation 
or Degradation of the 35-kD Fragment 
Fig. 8 shows that TLCK does not inhibit the degradation of 
the 35-kD fragment in transfected fibroblasts. 3T3 cells ex- 
pressing wild-type H2a were pulsed labeled and then chased 
in the presence of 0.5 mM cycloheximide which causes all 
precursor H2a to be converted to a 35-kD fragment which 
is not further metabolized (Fig. 8, lane 1, solid arrow) (see 
WikstrSm and Lodish,  1991).  The cyclobeximide was then 
removed and the chase continued for up to 3 h without any 
inhibitor (lanes 2, 4,  and 6) or in the presence of 100 #M 
TLCK (lanes 3, 5, and 7). The 35-ki) fragment is degraded 
rapidly both in the absence of inhibitors and in the presence 
of 100 #M TLCK. The same result is observed when TPCK 
is used instead of TLCK (data not shown). Therefore, degra- 
dation of the 35-kD fragment is not blocked by TLCK or 
TPCK. 
Fig. 9 a  shows that in transfected fibroblasts TLCK does 
not block the formation of 35-kD fragment from wild-type 
H2a.  The  overall  degradation  of the  pulse  labeled  core- 
glycosylated H2a precursor (Fig.  9,  lane 1, solid arrow) is 
inhibited by 100 #M TLCK (lanes 5-7) compared to lanes 
2-4 (chase without any inhibitor). When the chase medium 
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fragment. (a) Transfected cells. 3T3 cells expressing wild-type H2a 
were pulse  labeled with 0.3 mCi/ml of [35S]Cys for 15 min and 
then chased in unlabeled complete medium containing various in- 
hibitors for up to 5 h. Immunoprecipitates  of cell lysates at 0, 100, 
200,  and  300  min of chase were  analyzed  by SDS-PAGE and 
fluorography. Lane 1:  Pulse labeled only. Lanes 2-4: Chased  in 
medium without any inhibitor. Lanes 5-7: Chased in the presence 
of 100 #M TLCK. Lanes 8-10: Chased in the presence of 100 #M 
TLCK and 0.5  mM cycloheximide.  Lanes  11-13: Chased  in the 
presence of 0.5 mM cycloheximide. The solid arrow indicates the 
position of the core-glycosylated ER precursor and the open arrow 
the position of the 35-kD fragment.  (b) Cell free translation reac- 
tions.  H2a mRNA was translated with [35S]Cys in a rabbit reticu- 
locyte lysate with dog pancreatic microsomes for 2 h in the absence 
of inhibitor  (lane/) or in the presence  of TLCK (lanes 2-5) or 
TPCK (lanes 6--9). Inhibitors were added to the translation mixture 
and the reactions were incubated for 30 min at 30°C before addition 
of RNA. At the end of the reaction, microsomes were pelleted and 
then solubilized in lysis buffer. Samples were immunoprecipitated 
with antisera  specific for the H2 carboxy terminus,  treated with 
Endo H, and analyzed by SDS-PAGE and fluorography. The solid 
arrow indicates the position of  the intact protein and the open arrow 
the position of the cleavage fragment. 
contained both 100/zM TLCK and 0.5 mM cycloheximide 
(lanes  8-10),  40%  as  much 35-kD  fragment accumulated 
during the chase period as in samples (lanes 11-13) in which 
only cycloheximide is present.  Thus TLCK does not block 
formation of the 35-kD fragment. 
Fig.  9 b  shows that up to 400 #M of TLCK or 200/zM 
of TPCK have no effect on formation of the 35-kD fragment 
during in vitro translation of the H2a protein in the presence 
of microsomes (open arrow). In this experiment the inhibi- 
tors were preincubated in the translation mixture for 30 min 
before addition of mRNA and the concentrations of TLCK 
and TPCK used are well above those required for inhibition 
of H2 degradation in transfected fibroblasts. 
Therefore,  TLCK or TPCK blocks the  ER  degradation 
pathway of H2a that does not involve formation of the 35-kD 
fragment, but does not block either the formation or further 
degradation of the 35-kD fragment. This indicates that the 
cleavage event that forms the 35-kD fragment is only one of 
at least two pathways for the ER degradation of H2.  Since 
iodoacetamide has a  similar effect as TLCK and TPCK, it 
is likely that these compounds are inhibiting the same pro- 
tease, one that requires an essential sulfydryl group for ac- 
tivity. 
Discussion 
There Are at Least Two Pathways  for 
the ER Degradation of the H2 Subunit of the 
Asialoglycoprotein Receptor 
During ER degradation of the core-glycosylated precursors 
of both the  H2a and H2b subunits,  a  35-kD fragment ac- 
cumulates transiently and is ultimately degraded; it is formed 
by proteolytic cleavage in the exoplasmic domain near the 
transmembrane region (WikstriSm and Lodish, 1991,  1992). 
In the presence of cycloheximide all precursor H2 is con- 
v~rted to this intermediate,  which is degraded completely 
only after cycloheximide is removed. Thus, the proteolytic 
cleavage generating this 35-kD fragment was thought to be 
an obligatory step in ER degradation of H2 (Wikstr6m and 
Lodish, 1991).  Here, we show that this is not the only path- 
way for ER degradation. 
If the initial cleavage process that forms the 35-kD frag- 
ment is obligatory for ER degradation of H2, mutants which 
show a decrease in formation of the 35-kD fragment would 
be expected to have a  slower rate or extent of degradation. 
However, in transfected fibroblasts the ER precursors of mu- 
tant H2 proteins that do not generate a 35-kD fragment have 
similar rates of ER degradation to that of the H2 wild type 
and H2 mutants that do generate a 35-kD fragment (Fig. 6). 
It is unlikely these observations are due to very rapid degra- 
dation of a 35-kD fragment generated by precursors of some 
of the mutants,  so as to make them undetectable,  because 
they are not detected even in cells that have been treated with 
cycloheximide, which causes all pulse labeled wild-type H2 
precursor to be converted to a stable 35-kD fragment. This 
suggests that there is an alternate degradation pathway for the 
H2 protein in the ER that is not dependent on the cleavage 
process that generates the 35-kD fragment. 
In both Hep G2 cells and transfected 3T3 cells, TLCK and 
TPCK inhibit the degradation of both H2a and H2b precur- 
sors in the ER (Wikstr6m and Lodish,  1991,  1992).  It was 
then thought that formation of the 35-kD fragment is obliga- 
tory for the degradation of I-I2 in the ER and that the inhibi- 
tors work by blocking the formation of the 35-kD fragment. 
The main reason for thinking so was that little 35-kD frag- 
ment could be detected  in  pulse chase experiments when 
cells were treated with TLCK or TPCK.  Also,  cyclohexi- 
mide blocks further degradation of the 35-kD fragment; in 
its presence all precursor H2 is converted to a 35-kD frag- 
ment. However, we showed here that mutant H2 proteins that 
do not generate the 35-kD fragment in transfected fibroblasts 
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Figure 10. Model illustrating the 
two pathways for ER degradation 
of H2. 
are degraded in the ER at the same rate as those that do form 
the fragment. Furthermore, TLCK and TPCK are able to in- 
hibit the degradation of the mutants which do not form the 
fragment (Fig. 7). These results led us to postulate that two 
pathways exist for the degradation of the H2 protein and to 
reassess the role of TLCK and TPCK in the two degradation 
pathways.  We showed directly that the degradation of the 
35-kD fragment is not inhibited by TLCK or TPCK (Fig. 8). 
We also found that the 35-kD fragment does accumulate in 
cells when both TLCK and cycloheximide are present (Fig. 
9 a). Most likely, the 35-kD fragment is formed in the pres- 
ence of TLCK and absence of cycloheximide but is rapidly 
degraded and does not accumulate. Furthermore, formation 
of the 35-kD fragment during in vitro translation is not in- 
hibited by TLCK or TPCK (Fig. 9 b). Therefore, TLCK and 
TPCK neither block the formation nor the degradation of  the 
35-kD fragment. Thus, both the enzyme(s) that generate the 
fragment and those that degrade it are unlikely to be involved 
in the second ER degradative pathway, that not involving the 
35-kD fragment. As TLCK or TPCK can inhibit the ER deg- 
radation of the vast majority of pulse labeled H2, we think 
that the pathway not involving the 35-kD intermediate is nor- 
mally the major one and this is the pathway that is sensitive 
to TLCK and TPCK. Fig. 10 shows a model for the ER deg- 
radation of H2 that illustrates these two pathways of degrada- 
tion. Inoue and Simoni (1992) showed that the degradation of 
the T cell receptor c~ subunit and the HMG-CoA (3-hydroxy- 
3-methylglutaryl coenzyme A) reductase in the ER exhibit 
different  sensitivities  to  several protease  inhibitors.  This 
suggests that multiple mechanisms of  protein degradation ex- 
ist in the ER which affect different proteins.  The present 
study indicates that the same protein may be subjected to 
more than one degradation pathway. 
Wikstr6m and Lodish (1993) showed that, for the H2b pro- 
tein,  "~30%  of the  newly  synthesized  protein  becomes 
properly folded and is transported to the Golgi while the 
~70%  that is degraded in the ER is not properly folded. 
They also showed that inhibition of the ER degradation with 
TLCK or TPCK causes accumulation of unfolded forms of 
the protein within the ER.  Therefore, the ER degradation 
process that is inhibited by TLCK or TPCK recognizes the 
fraction of the protein that remains unfolded in the ER and 
targets them for degradation. Here we showed that the same 
fraction of ER precursors of mutant H2b proteins that do not 
generate  35-kD  fragment  (e.g.,  $81I,  S81W,  and  S81R) 
acquires complex oligosaccharides as does wild-type H2b or 
those mutants that do generate the 35-kD fragment.  This 
indicates  that  the  fraction of H2b precursor protein that 
folds properly in the ER, moves to the Golgi complex, and 
presumably is transported to the cell surface is not increased 
when formation of the 35-kD fragment in the ER is inhibited 
by mutation. 
Iodoacetamide has similar effect to those of TLCK and 
TPCK in inhibiting one of the pathways of ER degradation 
of H2. This suggests that this degradation system utilizes ac- 
tive sulfydryl group(s) or cysteine protease(s). Proteases of 
this class have been suggested to be involved in the ER degra- 
dation of the T cell receptor subunits (Wileman et al., 1991) 
and that of the HMG-CoA reductase (Inoue et al.,  1991). 
The Endoprotease That Cleaves H2 to 
Generate the 35-kD Fragment Has Properties Similar 
to Signal Peptidase 
By determining the NH2 termini of the 35-kD  fragments, 
we have localized the most likely proteolytic cleavage sites 
in both H2a and H2b (Fig. 1). The cleavage sites are slightly 
different in H2a and H2b but they are all near the putative 
transmembrane region on the exoplasmic side of the protein. 
H2b has only one putative cleavage site and H2a has two. 
The occurrence of endoproteolytic cleavage within the lu- 
men of the ER and the proximity of the cleavage sites to the 
transmembrane region suggests that the proteolytic enzyme 
involved in the cleavage may be a membrane protein. Al- 
though different sites are used for H2a and H2b, they are 
only a few amino acid residues away from each other and in 
both cases the residues  NH2-  and COOH-terminal to the 
cleavage sites are all small neutral or small polar amino acids 
(Thr, Gly, Ser, and Ala). One proteolytic enzyme in the ER 
membrane that is known to have preferences for such amino 
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substrate is signal peptidase (Dalbey and yon Heijne, 1992). 
Applying yon Heijne's algorithm for the prediction of sig- 
nal peptidase cleavage sites (yon Heijne, 1986) to the region 
of the H2b protein just exoplasmic to the transmembrane se- 
quence, the optimal site for signal peptidase action is be- 
tween Ser81  and Ala82, precisely the cleavage site deduced 
from our experiments.  However,  a  similar calculation for 
H2a indicates that the optimal signal peptidase cleavage site 
should be between Ser81 and Glu82, but the experimentally 
deduced sites are T77/G78  and G78/$79. 
H_2 is a type 2 transmembrane protein with a single trans- 
membrane region that functions during ER insertion as an 
uncleaved signal anchor (Spiess  and Lodish, 1985).  There 
are examples of type 2 signal-anchor sequences which are 
cleaved by signal peptidase, but only after removal of the 
amino-terminal cytosolic domain. One is the invariant chain 
of the Class II histocompatibility antigens (Lipp and Dob- 
berstein, 1986).  Another is the ASGP receptor H1 subunit. 
This is also a type 2 transmembrane protein that is 60% ho- 
mologous to H2 but it is normally not subjected to proteo- 
lytic cleavage when expressed in fibroblasts or synthesized 
by in vitro translation in the presence of pancreatic micro- 
somes. However, when the NH2-terminal cytosolic segment 
of the  protein  is  deleted,  the  transmembrane  region  is 
cleaved from the exoplasmic domain, most probably by sig- 
nal peptidase (Schmid and Spiess,  1988).  The NH:-termi- 
nal cytosolic domain of H1 may modulate the accessibility 
of the potential cleavage site in the transmembrane region. 
When the NH2-terminal cytosolic domain is removed, the 
site becomes accessible and the protein is cleaved. The site 
of cleavage of the mutant H1 lacking the NH2-terminal  do- 
main is between amino acids Gly60 and Ser61 of H1, num- 
bered according to wild-type H1 (Schmid and Spiess, 1988). 
The homologous site, G78/$79 in H2a is also one of the de- 
duced sites of endoproteolytic cleavage on precursor H2a. 
Thus, it is possible that H2 also has a potential site for signal 
peptidase cleavage at the COOH terminus of the transmem- 
brane region and perhaps the cytosolic domain of the H2 
protein is not as effective as that of H1 in preventing access 
of signal peptidase to this site. 
To determine the specificity of the endoproteolytic cleav- 
age that generates the 35-kD fragment, we mutated amino 
acid  residues  NH2- and  COOH-terminal  to  the  deduced 
cleavage sites.  All the mutants were analyzed both in vitro 
translation microsome-insertion systems and in transfected 
fibroblasts, and showed proper membrane insertion and core 
asparagine-linked glycosylation. Therefore any decrease in 
formation of the 35-kD fragment is not due to incompetence 
of the mutant protein for insertion in the ER membrane. In 
vitro translation studies of mRNA encoding mutant H2 pro- 
teins showed that the extent of formation of the 35-kD frag- 
ment was decreased (but not abolished) when the residue 
NH2-terminal to the cleavage site (Ser81)  was mutated to 
a large hydrophobic (Trp, Be) or charged residue (Arg, Lys). 
Conversely, mutation of Set81 to perhaps even more favor- 
able residues for signal peptidase cleavage (H2b S81A and 
$81G) increased the amount of 35-kD fragment formed. The 
same qualitative results were seen when these mutant pro- 
teins were synthesized in transfected fibroblasts: H2b mu- 
tants  S81W, S81I,  and SS1R  did not generate detectable 
amounts of the 35-kD fragment, while normal amounts of 
the fragment were produced in cells expressing mutants H2b 
S81A  and S81G. Mutant H2  proteins that generated low 
amounts of the 35-kD fragment during in vitro translation 
generated none in transfected cells. There are several possi- 
ble explanations, including tissue and species differences, 
dog pancreatic microsomes versus mouse fibroblasts, and 
differences in ionic and redox conditions in the experimental 
systems. However,  there is an excellent qualitative correla- 
tion between the two systems on the effect of mutations on 
formation of the 35-kD fragment. 
The 35-kD fragment produced in low amounts during the 
in vitro translation of the H2b SSII and S81R mutants had 
a  different NH2 terminus from that of the wild type, sug- 
gesting that a different cleavage site was used to generate the 
35-kD fragments. The presumed cleavage site, G78/$79,  is 
one of the two cleavage sites utilized to form the 35-kD frag- 
ment from H2a. This change in cleavage site may be due to 
the selection of the next most favorable site for cleavage by 
signal peptidase once the original site has been mutated to 
become unfavorable. This property of signal peptidase has 
been previously described (Folz et al.,  1988). 
When Ala82 in H2b, the residue COOH-terminal to the 
normal cleavage site, was mutated, there was no significant 
decrease in the amount of 35-kD fragment formed, either 
during  in  vitro  translations  or  in  transfected fibroblasts. 
However,  during in vitro translations the H2b A82G and 
A82P mutants were cleaved at G78/$79,  rather than at the 
wild-type cleavage site of $81/A82,  as judged from the NH2 
termini of the 35-kD fragments. As mentioned above,  the 
G78/$79 site is one of the cleavage sites utilized in H2a for 
generation of the 35-kD fragment. The H2b A82E and A82T 
mutants were cleaved at two sites, G78/$79 as well as the 
normal H2b site $81/A82,  whereas the H2b A82R mutant 
was only cleaved at $81/A82.  Thus cleavage  site selection 
may also be affected by changes in protein conformation that 
may be introduced by these mutations. Proline and glycine 
residues are most likely to affect the protein conformation 
by inducing/3-turns or breaking a  helices (Chou and Fas- 
man,  1978).  The  conformational changes  introduced by 
these amino acids may in turn affect the recognition of cleav- 
age sites by the protease and result in proteolytic cleavage at 
an alternative site. 
Single amino acid substitutions in H2a can inhibit forma- 
tion of the 35-kD fragment (see Table Ic) even though there 
are two putative cleavage sites. Similar to H2b, large hydro- 
phobic or positively charged residues NH2- or COOH-ter- 
minal to the putative cleavage sites are inhibitory to forma- 
tion of the 35-kD  fragment.  Interestingly, the H2a $79P 
mutant exhibits a marked decrease in extent of formation 
of the 35-kD fragment. This may be due to conformational 
changes introduced by the insertion of five extra amino acids 
in H2a which in turn affect the specificity of the proteolytic 
cleavage. It is also possible that different  enzymes cleave H2a 
and H2b to generate the 35-kD fragments. 
Folz et al. (1988) showed that the amino acid occupying 
the -1 position of the signal cleavage site is important in de- 
termining the efficiency and site selection of cleavage by eu- 
karyotic signal peptidase. They showed that small residues 
at the -1 position are preferred by signal peptidase. Noth- 
wehr and Gordon (1989) and Nothwehr et al. (1990) further 
demonstrated that conformational features of the signal se- 
quence influence the efficiency and position of cleavage. The 
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age that generates the H2 35-kD fragment, and the effects of 
introduction of amino acids that tend to change protein con- 
formation on the selection of the cleavage site, are similar to 
those exhibited by eukaryotic signal peptidase (reviewed by 
von Heijne, 1990; Dalbey and von Heijne, 1992). Therefore, 
the protease that cleaves H2 to produce the 35-kD fragment 
may be signal peptidase or another protease that has similar 
properties. As the putative cleavage sites of  the H2 wild type 
and mutants have been determined by NH2-terminal protein 
sequencing of the 35-kD fragments, we cannot rule out the 
possibility that all H2a and H2b mutants are initially cleaved 
by an endoprotease at the same site, and that differences of 
the NH2 termini of the various fragments analyzed are due 
to differential exoprotease activity at the NH2 terminus. 
Conformational Differences in the Juxtamembrane 
Region May Explain the Difference in Metabolic Fate 
between H2a and H2b 
H2a and H2b have different metabolic fates when expressed 
in fibroblasts. When H2b is expressed in fibroblasts in the 
absence of H1, ,,030  % of newly synthesized protein becomes 
folded normally, exits the ER, and reaches the cell surface 
while 70 % remains unfolded and is degraded in the ER. In 
contrast,  all H2a,  expressed in the absence of H1,  is de- 
graded within the ER (Lederkremer and Lodish, 1991; Wik- 
strtm and Lodish,  1991). H2b mutant proteins A82G and 
A82P, synthesized in transfected cells, have metabolic fates 
similar to that of wild-type H2a, not H2b. No newly made 
A82G and A82P mutant proteins acquire complex oligosac- 
charides, evidence that none exits the ER. The ER precursor 
proteins are degraded at the faster rate characteristic of H2a 
(Fig.  6  c).  Most interestingly, the cleavage site used  for 
generation of the A82G and A82P 35-kD fragments is one 
of those utilized by wild-type H2a,  rather than the Ser81/ 
Ala82 site used by wild-type H2b. Proline and glycine are 
residues commonly found in/S-turns of  proteins and the pen- 
tapeptide  (Glu-Gly-His-Arg-Gly) inserted  in H2a perhaps 
could form this type of secondary  structure  (Lederkremer 
and Lodish, 1991). Therefore, the H2b A82P and A82G mu- 
tants and wild-type H2a may have similar metabolic fates be- 
cause they have similar conformations in the juxtamembrane 
region. The introduction of a 13 turn in this region of  the pro- 
tein, either by the pentapeptide or by introduction of proline 
or glycine, may cause a change in the cleavage site that gen- 
erates the 35-kD fragment. This conformational change can 
also make the protein incapable of exiting the ER and thus, 
it becomes totally degraded within this organelle. It is possi- 
ble that the juxtamembrane region of H2 is critical for cor- 
rect  folding of the entire  exoplasmic domain because un- 
folded forms of  the protein do not exit the ER and are quickly 
degraded.  Alternatively, this region of the protein may not 
affect folding of the rest of the molecule, but certain confor- 
mations in this region (which would be disrupted in the H2b 
A82P and A82PG mutants and in wild-type H2a) may be es- 
sential for recognition by some factors that regulate ER-to- 
Golgi transport of plasma membrane proteins. It is interest- 
ing that only the H2b A82P and A82G mutants have meta- 
bolic fates similar to that to H2a; the H2b S81P and $81G 
mutants have metabolic fates similar to that of the wild-type 
H2b, suggesting that introduction of proline or glycine resi- 
dues only at certain specific positions can alter the metabolic 
fate of the H2 protein. 
The transmembrane domain of T cell receptor subunits is 
thought to be critical for targeting the proteins for ER degra- 
dation (Bonifacino et al., 1990, 1991; Wileman et al., 1991). 
In contrast,  our evidence suggests that the domain of the 
ASGP receptor H2 subunit that determines the rate and ex- 
tent of ER degradation is probably not within the transmem- 
brane domain but is in the juxtamembrane exoplasmic re- 
gion. This region modulates the fate of the H2 protein in the 
ER as shown by the difference in metabolic fate between H2a 
and H2b and the effect of introduction of proline and glycine 
residues  in this  region  of H2b. However, the  proteolytic 
cleavage in this region is not critical in determining the over- 
all rate of ER degradation, since mutant H2 proteins that do 
not generate the 35-kD fragment are degraded at the normal 
rate, presumably by the second pathway that does not involve 
formation of the 35-kD fragment (Fig.  10). 
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